Inspire Medical Systems, Inc. INSP
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 135.04M | 131.14M | 145.42M | 44.56M | 53.12M |
| Total Depreciation and Amortization | 17.21M | 16.02M | 13.96M | 12.61M | 10.79M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 42.18M | 46.45M | 44.98M | 133.94M | 130.72M |
| Change in Net Operating Assets | -37.35M | -57.08M | -87.38M | -57.42M | -77.18M |
| Cash from Operations | 157.07M | 136.53M | 116.98M | 133.69M | 117.45M |
| Capital Expenditure | -39.98M | -39.82M | -38.50M | -34.87M | -32.44M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 8.72M | 51.57M | 59.95M | 72.00M | -21.76M |
| Cash from Investing | -31.26M | 11.75M | 21.45M | 37.13M | -54.20M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.45M | 8.28M | 14.61M | 13.20M | 27.08M |
| Repurchase of Common Stock | -110.41M | -111.45M | -198.06M | -218.48M | -171.39M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -104.96M | -103.17M | -183.45M | -205.28M | -144.31M |
| Foreign Exchange rate Adjustments | -17.00K | -57.00K | -310.00K | -201.00K | -44.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 20.83M | 45.05M | -45.34M | -34.67M | -81.11M |